Hong Kwan Kim

Medicine and Dentistry

1. Non Small Cell Lung Cancer 100%
2. Lung Cancer 67%
3. Overall Survival 54%
4. Lobectomy 51%
5. Recurrent Disease 44%
6. Neoplasm 39%
7. Pneumonectomy 38%
8. Esophageal Squamous Cell Carcinoma 37%
9. Chemoradiotherapy 27%
10. Lung 27%
11. Esophagectomy 26%
12. Lung Adenocarcinoma 26%
13. Diseases 25%
14. Video-Assisted Thoracoscopic Surgery 24%
15. Prognostic Factor 23%
16. Malignant Neoplasm 21%
17. Recurrence Free Survival 20%
18. Survival Rate 19%
19. Positron Emission Tomography-Computed Tomography 19%
20. Disease Free Survival 18%
21. Tumor 17%
22. Hazard Ratio 17%
23. Computer Assisted Tomography 17%
24. Esophageal Cancer 16%
25. Retroperitoneal Lymph Node Dissection 15%
26. Lymph Node Metastasis 15%
27. Clinical Stage 13%
28. Lymph Node 13%
29. Surgery 13%
30. Cancer Staging 13%
31. Epidermal Growth Factor Receptor 12%
32. Radiation Therapy 11%
33. Non-Small Cell Lung Cancer 10%
34. Adenocarcinoma 10%
35. Long Term Survival 9%
36. Adjuvant Chemotherapy 9%
37. Median Follow Up 9%
38. Adjuvant Therapy 9%
39. Prevalence 9%
40. Ground Glass Opacity 8%
41. Colorectal Carcinoma 8%
42. Thymus Cancer 8%
43. Mucinous Carcinoma 8%
44. Metastasectomy 8%
45. Arm 8%
46. Neoadjuvant Therapy 8%
47. Treatment Outcome 8%
48. Esophageal Cancer 7%
49. Thoracotomy 7%
50. Chemoradiation Therapy 7%